nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—Infection—Triamcinolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Zoledronate—Infection—Methylprednisolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Zoledronate—Haematuria—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Zoledronate—Shock—Triamcinolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Zoledronate—Insomnia—Prednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Zoledronate—Alopecia—Prednisone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Zoledronate—Shock—Methylprednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Zoledronate—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Zoledronate—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Zoledronate—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Zoledronate—Paraesthesia—Prednisolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Zoledronate—Tachycardia—Triamcinolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Zoledronate—Mental disorder—Prednisone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Zoledronate—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Zoledronate—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Zoledronate—Malnutrition—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Zoledronate—Erythema—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Zoledronate—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Zoledronate—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Zoledronate—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Zoledronate—Convulsion—Betamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Zoledronate—Convulsion—Dexamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Zoledronate—Hypertension—Betamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Zoledronate—Hypertension—Dexamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Zoledronate—Myalgia—Betamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Zoledronate—Myalgia—Dexamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Zoledronate—Anxiety—Betamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Zoledronate—Anxiety—Dexamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Zoledronate—Discomfort—Betamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Zoledronate—Discomfort—Dexamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Zoledronate—Hypotension—Methylprednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Zoledronate—Pain—Prednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Zoledronate—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Zoledronate—Vision blurred—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Zoledronate—Urethral disorder—Methotrexate—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Zoledronate—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Zoledronate—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Zoledronate—Oedema—Betamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Zoledronate—Oedema—Dexamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Zoledronate—Insomnia—Triamcinolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zoledronate—Insomnia—Methylprednisolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zoledronate—Infection—Dexamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zoledronate—Infection—Betamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zoledronate—Ill-defined disorder—Prednisone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zoledronate—Paraesthesia—Triamcinolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zoledronate—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Zoledronate—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Zoledronate—Anaemia—Prednisone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Zoledronate—Shock—Betamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Zoledronate—Shock—Dexamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Zoledronate—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Zoledronate—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Zoledronate—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Zoledronate—Agitation—Prednisone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Zoledronate—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Zoledronate—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Zoledronate—Tachycardia—Dexamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Zoledronate—Tachycardia—Betamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Zoledronate—Angioedema—Prednisone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Zoledronate—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Zoledronate—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Zoledronate—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Zoledronate—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Zoledronate—Malaise—Prednisone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Zoledronate—Vertigo—Prednisone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Zoledronate—Eye disorder—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Zoledronate—Syncope—Prednisone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Zoledronate—Anorexia—Betamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Zoledronate—Anorexia—Dexamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Zoledronate—Urticaria—Prednisolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Zoledronate—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Zoledronate—Fatigue—Triamcinolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Zoledronate—Fatigue—Methylprednisolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Zoledronate—Pain—Triamcinolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Zoledronate—Loss of consciousness—Prednisone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Zoledronate—Hypotension—Dexamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Zoledronate—Hypotension—Betamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Zoledronate—Angiopathy—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Zoledronate—Immune system disorder—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Zoledronate—Convulsion—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Zoledronate—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Zoledronate—Hypertension—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Zoledronate—Chills—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Zoledronate—Arthralgia—Prednisone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Zoledronate—Myalgia—Prednisone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Zoledronate—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Zoledronate—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Zoledronate—Anxiety—Prednisone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Zoledronate—Alopecia—Methotrexate—psoriatic arthritis	0.001	0.001	CcSEcCtD
Zoledronate—Insomnia—Dexamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Zoledronate—Insomnia—Betamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000999	0.000999	CcSEcCtD
Zoledronate—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000996	0.000996	CcSEcCtD
Zoledronate—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000995	0.000995	CcSEcCtD
Zoledronate—Paraesthesia—Betamethasone—psoriatic arthritis	0.000995	0.000995	CcSEcCtD
Zoledronate—Discomfort—Prednisone—psoriatic arthritis	0.000994	0.000994	CcSEcCtD
Zoledronate—Mental disorder—Methotrexate—psoriatic arthritis	0.000994	0.000994	CcSEcCtD
Zoledronate—Malnutrition—Methotrexate—psoriatic arthritis	0.000988	0.000988	CcSEcCtD
Zoledronate—Erythema—Methotrexate—psoriatic arthritis	0.000988	0.000988	CcSEcCtD
Zoledronate—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000978	0.000978	CcSEcCtD
Zoledronate—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000975	0.000975	CcSEcCtD
Zoledronate—Dyspepsia—Betamethasone—psoriatic arthritis	0.000975	0.000975	CcSEcCtD
Zoledronate—Urticaria—Triamcinolone—psoriatic arthritis	0.00097	0.00097	CcSEcCtD
Zoledronate—Urticaria—Methylprednisolone—psoriatic arthritis	0.000968	0.000968	CcSEcCtD
Zoledronate—Dysgeusia—Methotrexate—psoriatic arthritis	0.000967	0.000967	CcSEcCtD
Zoledronate—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000965	0.000965	CcSEcCtD
Zoledronate—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000965	0.000965	CcSEcCtD
Zoledronate—Oedema—Prednisone—psoriatic arthritis	0.000965	0.000965	CcSEcCtD
Zoledronate—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000963	0.000963	CcSEcCtD
Zoledronate—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000963	0.000963	CcSEcCtD
Zoledronate—Decreased appetite—Betamethasone—psoriatic arthritis	0.000963	0.000963	CcSEcCtD
Zoledronate—Infection—Prednisone—psoriatic arthritis	0.000958	0.000958	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000956	0.000956	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000956	0.000956	CcSEcCtD
Zoledronate—Back pain—Methotrexate—psoriatic arthritis	0.000955	0.000955	CcSEcCtD
Zoledronate—Fatigue—Betamethasone—psoriatic arthritis	0.000955	0.000955	CcSEcCtD
Zoledronate—Fatigue—Dexamethasone—psoriatic arthritis	0.000955	0.000955	CcSEcCtD
Zoledronate—Shock—Prednisone—psoriatic arthritis	0.000949	0.000949	CcSEcCtD
Zoledronate—Pain—Betamethasone—psoriatic arthritis	0.000947	0.000947	CcSEcCtD
Zoledronate—Pain—Dexamethasone—psoriatic arthritis	0.000947	0.000947	CcSEcCtD
Zoledronate—Nervous system disorder—Prednisone—psoriatic arthritis	0.000946	0.000946	CcSEcCtD
Zoledronate—Tachycardia—Prednisone—psoriatic arthritis	0.000941	0.000941	CcSEcCtD
Zoledronate—Skin disorder—Prednisone—psoriatic arthritis	0.000937	0.000937	CcSEcCtD
Zoledronate—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000932	0.000932	CcSEcCtD
Zoledronate—Vision blurred—Methotrexate—psoriatic arthritis	0.000931	0.000931	CcSEcCtD
Zoledronate—Anorexia—Prednisone—psoriatic arthritis	0.000919	0.000919	CcSEcCtD
Zoledronate—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000916	0.000916	CcSEcCtD
Zoledronate—Anaemia—Methotrexate—psoriatic arthritis	0.000913	0.000913	CcSEcCtD
Zoledronate—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000913	0.000913	CcSEcCtD
Zoledronate—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000913	0.000913	CcSEcCtD
Zoledronate—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000906	0.000906	CcSEcCtD
Zoledronate—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000906	0.000906	CcSEcCtD
Zoledronate—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000899	0.000899	CcSEcCtD
Zoledronate—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000897	0.000897	CcSEcCtD
Zoledronate—Malaise—Methotrexate—psoriatic arthritis	0.000891	0.000891	CcSEcCtD
Zoledronate—Vertigo—Methotrexate—psoriatic arthritis	0.000887	0.000887	CcSEcCtD
Zoledronate—Leukopenia—Methotrexate—psoriatic arthritis	0.000884	0.000884	CcSEcCtD
Zoledronate—Urticaria—Dexamethasone—psoriatic arthritis	0.00088	0.00088	CcSEcCtD
Zoledronate—Urticaria—Betamethasone—psoriatic arthritis	0.00088	0.00088	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000879	0.000879	CcSEcCtD
Zoledronate—Dizziness—Prednisolone—psoriatic arthritis	0.000878	0.000878	CcSEcCtD
Zoledronate—Asthenia—Triamcinolone—psoriatic arthritis	0.000876	0.000876	CcSEcCtD
Zoledronate—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000876	0.000876	CcSEcCtD
Zoledronate—Abdominal pain—Betamethasone—psoriatic arthritis	0.000876	0.000876	CcSEcCtD
Zoledronate—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000876	0.000876	CcSEcCtD
Zoledronate—Body temperature increased—Betamethasone—psoriatic arthritis	0.000876	0.000876	CcSEcCtD
Zoledronate—Asthenia—Methylprednisolone—psoriatic arthritis	0.000874	0.000874	CcSEcCtD
Zoledronate—Insomnia—Prednisone—psoriatic arthritis	0.000872	0.000872	CcSEcCtD
Zoledronate—Paraesthesia—Prednisone—psoriatic arthritis	0.000866	0.000866	CcSEcCtD
Zoledronate—Pruritus—Triamcinolone—psoriatic arthritis	0.000864	0.000864	CcSEcCtD
Zoledronate—Cough—Methotrexate—psoriatic arthritis	0.000862	0.000862	CcSEcCtD
Zoledronate—Pruritus—Methylprednisolone—psoriatic arthritis	0.000862	0.000862	CcSEcCtD
Zoledronate—Convulsion—Methotrexate—psoriatic arthritis	0.000856	0.000856	CcSEcCtD
Zoledronate—Dyspepsia—Prednisone—psoriatic arthritis	0.000849	0.000849	CcSEcCtD
Zoledronate—Arthralgia—Methotrexate—psoriatic arthritis	0.000841	0.000841	CcSEcCtD
Zoledronate—Chest pain—Methotrexate—psoriatic arthritis	0.000841	0.000841	CcSEcCtD
Zoledronate—Myalgia—Methotrexate—psoriatic arthritis	0.000841	0.000841	CcSEcCtD
Zoledronate—Decreased appetite—Prednisone—psoriatic arthritis	0.000838	0.000838	CcSEcCtD
Zoledronate—Rash—Prednisolone—psoriatic arthritis	0.000837	0.000837	CcSEcCtD
Zoledronate—Dermatitis—Prednisolone—psoriatic arthritis	0.000836	0.000836	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000835	0.000835	CcSEcCtD
Zoledronate—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000833	0.000833	CcSEcCtD
Zoledronate—Fatigue—Prednisone—psoriatic arthritis	0.000832	0.000832	CcSEcCtD
Zoledronate—Headache—Prednisolone—psoriatic arthritis	0.000832	0.000832	CcSEcCtD
Zoledronate—Discomfort—Methotrexate—psoriatic arthritis	0.000831	0.000831	CcSEcCtD
Zoledronate—Constipation—Prednisone—psoriatic arthritis	0.000825	0.000825	CcSEcCtD
Zoledronate—Confusional state—Methotrexate—psoriatic arthritis	0.000813	0.000813	CcSEcCtD
Zoledronate—Dizziness—Triamcinolone—psoriatic arthritis	0.000807	0.000807	CcSEcCtD
Zoledronate—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000806	0.000806	CcSEcCtD
Zoledronate—Dizziness—Methylprednisolone—psoriatic arthritis	0.000805	0.000805	CcSEcCtD
Zoledronate—Infection—Methotrexate—psoriatic arthritis	0.000801	0.000801	CcSEcCtD
Zoledronate—Feeling abnormal—Prednisone—psoriatic arthritis	0.000795	0.000795	CcSEcCtD
Zoledronate—Asthenia—Betamethasone—psoriatic arthritis	0.000795	0.000795	CcSEcCtD
Zoledronate—Asthenia—Dexamethasone—psoriatic arthritis	0.000795	0.000795	CcSEcCtD
Zoledronate—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000791	0.000791	CcSEcCtD
Zoledronate—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000789	0.000789	CcSEcCtD
Zoledronate—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000789	0.000789	CcSEcCtD
Zoledronate—Nausea—Prednisolone—psoriatic arthritis	0.000788	0.000788	CcSEcCtD
Zoledronate—Pruritus—Dexamethasone—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Zoledronate—Pruritus—Betamethasone—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Zoledronate—Skin disorder—Methotrexate—psoriatic arthritis	0.000783	0.000783	CcSEcCtD
Zoledronate—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000779	0.000779	CcSEcCtD
Zoledronate—Vomiting—Triamcinolone—psoriatic arthritis	0.000776	0.000776	CcSEcCtD
Zoledronate—Vomiting—Methylprednisolone—psoriatic arthritis	0.000774	0.000774	CcSEcCtD
Zoledronate—Rash—Triamcinolone—psoriatic arthritis	0.00077	0.00077	CcSEcCtD
Zoledronate—Dermatitis—Triamcinolone—psoriatic arthritis	0.000769	0.000769	CcSEcCtD
Zoledronate—Anorexia—Methotrexate—psoriatic arthritis	0.000768	0.000768	CcSEcCtD
Zoledronate—Rash—Methylprednisolone—psoriatic arthritis	0.000768	0.000768	CcSEcCtD
Zoledronate—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000767	0.000767	CcSEcCtD
Zoledronate—Urticaria—Prednisone—psoriatic arthritis	0.000766	0.000766	CcSEcCtD
Zoledronate—Headache—Triamcinolone—psoriatic arthritis	0.000765	0.000765	CcSEcCtD
Zoledronate—Headache—Methylprednisolone—psoriatic arthritis	0.000763	0.000763	CcSEcCtD
Zoledronate—Abdominal pain—Prednisone—psoriatic arthritis	0.000762	0.000762	CcSEcCtD
Zoledronate—Body temperature increased—Prednisone—psoriatic arthritis	0.000762	0.000762	CcSEcCtD
Zoledronate—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000758	0.000758	CcSEcCtD
Zoledronate—Diarrhoea—Betamethasone—psoriatic arthritis	0.000758	0.000758	CcSEcCtD
Zoledronate—Hypotension—Methotrexate—psoriatic arthritis	0.000753	0.000753	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000734	0.000734	CcSEcCtD
Zoledronate—Dizziness—Dexamethasone—psoriatic arthritis	0.000732	0.000732	CcSEcCtD
Zoledronate—Dizziness—Betamethasone—psoriatic arthritis	0.000732	0.000732	CcSEcCtD
Zoledronate—Insomnia—Methotrexate—psoriatic arthritis	0.000729	0.000729	CcSEcCtD
Zoledronate—Nausea—Triamcinolone—psoriatic arthritis	0.000725	0.000725	CcSEcCtD
Zoledronate—Paraesthesia—Methotrexate—psoriatic arthritis	0.000724	0.000724	CcSEcCtD
Zoledronate—Nausea—Methylprednisolone—psoriatic arthritis	0.000723	0.000723	CcSEcCtD
Zoledronate—Dyspnoea—Methotrexate—psoriatic arthritis	0.000719	0.000719	CcSEcCtD
Zoledronate—Somnolence—Methotrexate—psoriatic arthritis	0.000717	0.000717	CcSEcCtD
Zoledronate—Hypersensitivity—Prednisone—psoriatic arthritis	0.000711	0.000711	CcSEcCtD
Zoledronate—Dyspepsia—Methotrexate—psoriatic arthritis	0.00071	0.00071	CcSEcCtD
Zoledronate—Vomiting—Betamethasone—psoriatic arthritis	0.000704	0.000704	CcSEcCtD
Zoledronate—Vomiting—Dexamethasone—psoriatic arthritis	0.000704	0.000704	CcSEcCtD
Zoledronate—Decreased appetite—Methotrexate—psoriatic arthritis	0.000701	0.000701	CcSEcCtD
Zoledronate—Rash—Betamethasone—psoriatic arthritis	0.000698	0.000698	CcSEcCtD
Zoledronate—Rash—Dexamethasone—psoriatic arthritis	0.000698	0.000698	CcSEcCtD
Zoledronate—Dermatitis—Betamethasone—psoriatic arthritis	0.000698	0.000698	CcSEcCtD
Zoledronate—Dermatitis—Dexamethasone—psoriatic arthritis	0.000698	0.000698	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000696	0.000696	CcSEcCtD
Zoledronate—Fatigue—Methotrexate—psoriatic arthritis	0.000695	0.000695	CcSEcCtD
Zoledronate—Headache—Betamethasone—psoriatic arthritis	0.000694	0.000694	CcSEcCtD
Zoledronate—Headache—Dexamethasone—psoriatic arthritis	0.000694	0.000694	CcSEcCtD
Zoledronate—Asthenia—Prednisone—psoriatic arthritis	0.000692	0.000692	CcSEcCtD
Zoledronate—Pain—Methotrexate—psoriatic arthritis	0.000689	0.000689	CcSEcCtD
Zoledronate—Pruritus—Prednisone—psoriatic arthritis	0.000682	0.000682	CcSEcCtD
Zoledronate—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000664	0.000664	CcSEcCtD
Zoledronate—Diarrhoea—Prednisone—psoriatic arthritis	0.00066	0.00066	CcSEcCtD
Zoledronate—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000659	0.000659	CcSEcCtD
Zoledronate—Nausea—Dexamethasone—psoriatic arthritis	0.000658	0.000658	CcSEcCtD
Zoledronate—Nausea—Betamethasone—psoriatic arthritis	0.000658	0.000658	CcSEcCtD
Zoledronate—Urticaria—Methotrexate—psoriatic arthritis	0.00064	0.00064	CcSEcCtD
Zoledronate—Dizziness—Prednisone—psoriatic arthritis	0.000638	0.000638	CcSEcCtD
Zoledronate—Abdominal pain—Methotrexate—psoriatic arthritis	0.000637	0.000637	CcSEcCtD
Zoledronate—Body temperature increased—Methotrexate—psoriatic arthritis	0.000637	0.000637	CcSEcCtD
Zoledronate—Vomiting—Prednisone—psoriatic arthritis	0.000613	0.000613	CcSEcCtD
Zoledronate—Rash—Prednisone—psoriatic arthritis	0.000608	0.000608	CcSEcCtD
Zoledronate—Dermatitis—Prednisone—psoriatic arthritis	0.000608	0.000608	CcSEcCtD
Zoledronate—Headache—Prednisone—psoriatic arthritis	0.000604	0.000604	CcSEcCtD
Zoledronate—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000594	0.000594	CcSEcCtD
Zoledronate—Asthenia—Methotrexate—psoriatic arthritis	0.000578	0.000578	CcSEcCtD
Zoledronate—Nausea—Prednisone—psoriatic arthritis	0.000573	0.000573	CcSEcCtD
Zoledronate—Pruritus—Methotrexate—psoriatic arthritis	0.00057	0.00057	CcSEcCtD
Zoledronate—Diarrhoea—Methotrexate—psoriatic arthritis	0.000552	0.000552	CcSEcCtD
Zoledronate—Dizziness—Methotrexate—psoriatic arthritis	0.000533	0.000533	CcSEcCtD
Zoledronate—Vomiting—Methotrexate—psoriatic arthritis	0.000513	0.000513	CcSEcCtD
Zoledronate—Rash—Methotrexate—psoriatic arthritis	0.000508	0.000508	CcSEcCtD
Zoledronate—Dermatitis—Methotrexate—psoriatic arthritis	0.000508	0.000508	CcSEcCtD
Zoledronate—Headache—Methotrexate—psoriatic arthritis	0.000505	0.000505	CcSEcCtD
Zoledronate—Nausea—Methotrexate—psoriatic arthritis	0.000479	0.000479	CcSEcCtD
